What is the primary route of absorption for most NSAIDs?
Master all 28 flashcards
In-depth review of absorption, distribution, metabolism, and excretion of NSAIDs, along with their pharmacodynamic effects on inflammation.
By mastering this deck, learners will understand how NSAIDs are absorbed, distributed, metabolized, and excreted, enabling them to predict drug behavior, optimize dosing, and anticipate patient responses in clinical settings involving anti-inflammatory therapy.
ℹ️ Educational Use Only: This flashcard deck is created by usersof our platform for their educational and study purposes. The content is not intended as medical advice, diagnosis, or treatment guidance. Always consult qualified healthcare professionals for medical decisions and verify information with authoritative medical sources.
Showing 20 of 28 cardsSample view
| # | Front | Back | Hint |
|---|---|---|---|
| 1 | What is the primary route of absorption for most NSAIDs? | Most NSAIDs are absorbed efficiently via the gastrointestinal tract, primarily in the small intestine, due to their lipophilic nature which facilitates passive diffusion. | Think of NSAIDs crossing cell membranes easily—like fats passing through membranes. |
| 2 | How does protein binding influence NSAID pharmacokinetics? | NSAIDs are highly bound to plasma albumin (>90%), which affects their distribution, free (active) drug concentration, and potential for drug interactions. | Remember: high protein binding can lead to displacement interactions and influence free drug levels. |
| 3 | Which enzyme is primarily responsible for NSAID metabolism? | NSAIDs are mainly metabolized in the liver by cytochrome P450 enzymes, especially CYP2C9. | CYP2C9 is a key enzyme—think of it as the 'metabolism worker' for many NSAIDs. |
| 4 | What is the primary route of NSAID excretion? | NSAIDs are primarily excreted via the kidneys through renal filtration and active tubular secretion as unchanged drug and metabolites. | Remember: renal excretion is crucial for drug clearance. |
| 5 | Describe the pharmacodynamic mechanism of NSAIDs in reducing inflammation. | NSAIDs inhibit cyclooxygenase (COX) enzymes, mainly COX-1 and COX-2, decreasing prostaglandin synthesis, which mediates inflammation, pain, and fever. | Think of NSAIDs as 'blockers' of prostaglandin production. |
| 6 | What is the difference between COX-1 and COX-2 inhibition regarding therapeutic effects and side effects? | COX-1 inhibition affects protective prostaglandins in the gastric mucosa and platelet aggregation, leading to side effects like gastric ulcers; COX-2 inhibition mainly reduces inflammation and pain with fewer gastrointestinal side effects. | Selective COX-2 inhibitors aim to spare COX-1 to reduce GI toxicity. |
| 7 | How does the half-life of NSAIDs influence dosing frequency? | NSAIDs with short half-lives (e.g., ibuprofen) require more frequent dosing, whereas those with longer half-lives (e.g., piroxicam) can be dosed less frequently. | Half-life determines how often you need to 're-up' the medication. |
| 8 | Why is hepatic metabolism important in NSAID clearance? | Hepatic metabolism converts NSAIDs into more water-soluble metabolites, facilitating renal excretion and affecting drug accumulation in cases of liver impairment. | Liver function can influence NSAID levels—think of the liver as the body's chemical processor. |
| 9 | Name an NSAID that is primarily excreted unchanged in the urine. | Sulindac is partially excreted unchanged, but many NSAIDs are extensively metabolized; however, some NSAIDs like ketoprofen and naproxen are excreted as unchanged drugs to some extent. | Most NSAIDs are metabolized, but check specific drugs for excretion details. |
| 10 | What pharmacodynamic effect do NSAIDs have on pain and fever? | NSAIDs reduce pain and fever by decreasing prostaglandin synthesis, which sensitize pain receptors and mediate fever response. | Think of prostaglandins as mediators of pain and fever, which NSAIDs block. |
| 11 | How does chronic use of NSAIDs affect renal function? | Chronic NSAID use can impair renal function by inhibiting prostaglandins that maintain renal blood flow, potentially leading to nephrotoxicity or acute kidney injury. | Prostaglandins protect kidney perfusion—block them, and kidney function may decline. |
| 12 | What is the clinical significance of NSAID half-life in managing inflammatory conditions? | Understanding NSAID half-life helps determine dosing intervals to maintain effective plasma concentrations while minimizing toxicity. | Longer half-life drugs allow less frequent dosing—think convenience and compliance. |
| 13 | Explain the role of first-pass metabolism in NSAID pharmacokinetics. | NSAIDs undergo significant first-pass hepatic metabolism after oral administration, which can reduce bioavailability depending on the drug's extent of first-pass effect. | First-pass metabolism is the liver's initial processing—think of it as the 'filter' after oral ingestion. |
| 14 | Which NSAID has the highest protein binding affinity and how does this affect drug interactions? | Diclofenac has high protein binding (>99%), increasing potential for displacement interactions with other highly bound drugs, potentially elevating free drug levels. | High protein binding means more potential for interactions—like a crowded bus with limited seats. |
| 15 | Describe how NSAID pharmacokinetics differ in patients with hepatic impairment. | Hepatic impairment can reduce metabolism of NSAIDs, leading to increased plasma concentrations and risk of toxicity, necessitating dose adjustments. | Liver problems slow down drug clearance—think of the liver as the body's chemical 'factory.' |
| 16 | What is the significance of NSAID selectivity for COX enzymes in pharmacodynamics? | Selectivity for COX-2 reduces gastrointestinal side effects but may increase cardiovascular risks; non-selective NSAIDs inhibit both COX-1 and COX-2, affecting both inflammation and gastric protection. | Balancing efficacy and safety depends on COX selectivity. |
| 17 | How do NSAIDs affect platelet function? | NSAIDs like aspirin irreversibly inhibit COX-1 in platelets, decreasing thromboxane A2 production and impairing platelet aggregation, which prolongs bleeding time. | Aspirin's effect on platelets is like 'permanent' until new platelets are formed. |
| 18 | Why are NSAIDs contraindicated in patients with chronic kidney disease? | NSAIDs can impair renal perfusion by inhibiting prostaglandins, worsening renal function in CKD patients and increasing the risk of nephrotoxicity. | Remember: NSAIDs can harm the kidneys, especially when already compromised. |
| 19 | What is the typical time to reach peak plasma concentration for oral NSAIDs? | Most oral NSAIDs reach peak plasma levels within 1 to 2 hours after administration. | Peak levels are usually quick—think of the drug 'hitting the peak' in about an hour or two. |
| 20 | Explain the concept of enterohepatic recirculation and its relevance to NSAIDs. | Some NSAIDs undergo enterohepatic recirculation, where they are secreted into bile, reabsorbed in the intestine, and re-enter circulation, prolonging their half-life. | Think of it as recycling—bile helps the drug stay longer in the system. |
Note: This preview shows only the first 20 cards. The complete deck contains 28 total cards. Start studying to access all flashcards.
Master all 28 flashcards
Explore other decks you might find helpful